Genome & Co

314130

Company Profile

  • Business description

    Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

  • Contact

    Innovalley A-801
    Pangyo-ro 253, Bundang-gu
    Gyeonggi-do
    Seongnam-si13486
    KOR

    T: +82 316280150

    http://www.genomecom.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    92

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,789.461.360.02%
DAX 4023,972.8165.38-0.27%
Dow JONES (US)42,101.572.870.01%
FTSE 1008,726.320.310.00%
HKSE23,573.38315.071.35%
NASDAQ19,244.89143.950.75%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,913.0224.470.42%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers